Compare TLSA & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLSA | LODE |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.2M | 167.1M |
| IPO Year | 2017 | 2004 |
| Metric | TLSA | LODE |
|---|---|---|
| Price | $1.35 | $3.21 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 127.8K | ★ 1.0M |
| Earning Date | 05-06-2025 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.55 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,553,796.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,451.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.73 | $1.67 |
| 52 Week High | $2.60 | $4.80 |
| Indicator | TLSA | LODE |
|---|---|---|
| Relative Strength Index (RSI) | 49.79 | 54.28 |
| Support Level | $1.27 | $3.03 |
| Resistance Level | $1.59 | $3.43 |
| Average True Range (ATR) | 0.10 | 0.21 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 60.00 | 67.96 |
Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.